@article{ba537f67b7c447c99b74f3f5ea4bb026,
title = "Prime time for doxorubicin-induced cardiotoxicity genetic testing",
keywords = "cardiotoxicity, chemotherapy, clinical translation, human-induced pluripotent stem cells, pharmacogenomics",
author = "Tarek Magdy and Burridge, {Paul W.}",
note = "Funding Information: This work was supported by NIH NCI grant no. R01 CA220002 to PWB. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript.",
year = "2022",
month = apr,
doi = "10.2217/pgs-2022-0032",
language = "English (US)",
volume = "23",
pages = "335--338",
journal = "Pharmacogenomics",
issn = "1462-2416",
publisher = "Future Medicine Ltd.",
number = "6",
}
